Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Compugen Ltd.
DescriptionAn Fc fusion protein with the extracellular region of a B7/CD28-like protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today